source
- Claret Capital Partners raises €575 million Fund IV to boost European biotech lendingClaret Capital Partners, a European investment firm, announced that its fourth fund has closed at €575 million. The firm said a significant share of the capital will be deployed as loans to life-s…
- BrainChild Bio masterminds $116M series A for CAR-T's pivotal push in pediatric brain cancerA startup spawned from Seattle Children’s Hospital has raised a $116 million series A to advance cell therapies for devastating childhood brain tumors.